Protenus

Protenus

Protenus - A new approach to protecting patient privacy and defending hospitals against HIPAA violations.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor investor

€0.0

round
*

N/A

Acquisition
Total Funding000k
Notes (0)
More about Protenus
Made with AI
Edit

Established in 2014 by co-founders Nick Culbertson and Robert Lord, Protenus operates within the healthcare technology sector, providing artificial intelligence-driven solutions to mitigate risk for healthcare organizations. The founders' backgrounds are deeply rooted in the intelligence community and data science; Culbertson served as a US Army intelligence officer and Lord was a data scientist at the Johns Hopkins University Applied Physics Laboratory. This experience directly informs the company's approach to sifting through vast amounts of data to detect anomalous behavior, a skill set they translated from national security to patient privacy and security.

The company's core business revolves around its Patient Privacy Monitoring and Drug Diversion Surveillance platform. This platform helps hospitals and health systems protect sensitive patient data and prevent the theft of controlled substances. Protenus serves a client base of healthcare organizations, offering them tools to ensure compliance with regulations like HIPAA and to combat the growing issue of drug diversion within their facilities. The business model is based on providing these risk-reduction solutions as a service, presumably through a subscription or licensing fee structure. The platform analyzes every access to patient data within a hospital's electronic health record system, using AI to identify inappropriate access patterns. For drug diversion, the system scrutinizes the entire medication lifecycle—from procurement to administration—to detect suspicious activities that could indicate theft for personal use or sale.

Protenus has achieved several key milestones, including securing multiple rounds of funding to fuel its growth and product development. For instance, the company raised $21 million in a Series D funding round in 2021, bringing its total funding to over $50 million at the time. Throughout its history, Protenus has garnered industry recognition, being named to various prestigious lists such as the Forbes list of America's Best Startup Employers and Modern Healthcare's Best Places to Work. Keywords: healthcare AI, patient privacy monitoring, drug diversion surveillance, healthcare compliance, risk reduction, electronic health records, data security, health data analytics, HIPAA, controlled substances

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo